Trade Compass Therapeutics, Inc. - CMPX CFD
What is Compass Therapeutics, Inc. (CMPX)?
Compass Therapeutics, Inc. is a biotechnology company focused on the development of antibody-based therapies. It specializes in creating monoclonal antibodies targeting diseases such as cancer and autoimmune disorders. The company employs proprietary technologies to discover and optimize therapeutic antibodies with potential clinical applications. Compass Therapeutics engages in research and development activities aimed at advancing its pipeline of drug candidates. It collaborates with academic institutions and industry partners to support its innovation efforts. The company operates within the biopharmaceutical sector, contributing to the development of novel treatments addressing unmet medical needs.
Compass Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing trading activity, as Compass Therapeutics, Inc. is priced at $5.47. The price has fluctuated between $5.13 and $5.47, registering a daily percentage change of +0.1852%.
FAQ: Compass Therapeutics, Inc. (CMPX)
What is the current price of CMPX stock?
The last traded price is $5.47.
Does CMPX pay dividends?
Dividends are not paid.
Does CMPX have a formal corporate presence or regional headquarters in the UAE?
Compass Therapeutics, Inc. operates in the UAE through partners and distributors without an official regional office or subsidiary.
What is CMPX best known for?
The company is most famous for its development of innovative immunotherapies.
What assets are typically shown together with CMPX?
Commonly shown alongside CMPX: Starbucks Corp, Ericsson - ADS each representin, Avidity Biosciences Inc
Latest shares articles



